Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CORTLANDT MANOR, N.Y., June 10, 2013 /PRNewswire/ -- MedTest Holdings, the parent company of MedTest DX, Inc. (“MedTest”) has signed a definitive agreement to acquire Pointe Scientific, Inc. (“Pointe”) located in Canton, Michigan. Financial details of the acquisition were not disclosed. MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing.
Pointe has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981. Pointe’s robust R&D program focuses on continual improvement of existing products and bringing new products and technologies to the marketplace.
“We are thrilled to add the Pointe Scientific team to our family,” said Hanjoon Ryu, CEO of MedTest. “Combined, MedTest and Pointe become uniquely positioned to offer a broad range of clinical chemistry products and services for clinical laboratories and physician office laboratories worldwide. Going forward, we will continue to serve our customers with the same commitment to quality and customer service that both companies have proven in the past.”
Together, Pointe and MedTest offer a broad reagent and instrument product portfolio including testing solutions for drugs of abuse, general chemistry, immunochemistry, diabetes and cardiovascular diseases serving physician’s office laboratories, reference laboratories, hospital laboratories and commercial laboratories.
For more information, please contact Kay Newel at knewel@pointescientific.com, 734-487-8314 or Debbie Whitehair at DWhitehair@medtestdx.com, 484-748-1603.
SOURCE MedTest Holdings
Help employers find you! Check out all the jobs and post your resume.
